4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-15-072636
Options or other derivatives
- Chief Operating Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BRISSON MARY CATHERINE · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-12-22 | Grant or award : show line 1 in the form Share Option (Right to Buy) | +10,000 | 10,000 | D |
Loading xslF345X03/v427687_4.xml…